Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05737979
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2023-02-10
Brief Title:
Modified Rekovelle and Menopur Combination Protocol to Avoid Monitoring Before Day 10 of Stimulation
Sponsor:
Clinique Ovo
Organization:
Clinique Ovo
Study Overview
Official Title:
Modified Rekovelle and Menopur Combination Protocol to Avoid Monitoring Before Day 10 of Stimulation
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Follitropin delta Rekovelle algorithm established by Ferring provides personalized gonadotrophin doses based on each patients weight and AMH As a result risks of stimulation failure or ovarian hyperstimulation syndrome OHSS during an in vitro fertilization IVF cycle are minimized
As a standard practice for OHSS prevention at clinique ovo women undergoing IVF will have a scheduled ultrasound and blood test on the sixth day of their stimulation treatment However with the determination of the Rekovelle and Menopur algorithm the risks of OHSS before the tenth day have been considerably minimized
As a standard practice for OHSS prevention at clinique ovo women undergoing IVF will have a scheduled ultrasound and blood test on the sixth day of their stimulation treatment However with the determination of the Rekovelle and Menopur algorithm the risks of OHSS before the tenth day have been considerably minimized
Detailed Description:
The purpose of this study is to evaluate the necessity of programming an ultrasound and blood test prior to the tenth day of ovarian stimulation when women are on personalized doses of Rekovelle and Menopur duting an antagonist IVF cycle Based on the results of the analysis we will assess the economic impact that programming an ultrasound and blood test at day 10 might have
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None